Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics (Q44588093)

4 December 2017

title

Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics (English)

1 reference

acute myocardial infarction

4 December 2017

main subject

myocardial infarction

1 reference

1 reference

1 reference

Jose F Huizar

1

1 reference

4 December 2017

Luis A Gonzalez

series ordinal

2

1 reference

4 December 2017

James Alderman

series ordinal

3

1 reference

4 December 2017

Harton S Smith

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Journal of the American College of Cardiology

4 December 2017

published in

1 reference

4 December 2017

volume

42

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

1017-1021

1 reference

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Function, regulation, pharmacology, and molecular structure of ATP-sensitive K+ channels in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

The sulfonylurea controversy: more questions from the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Role of ATP-sensitive K+ channel on ECG ST segment elevation during a bout of myocardial ischemia. A study on epicardial mapping in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Intracellular targets for antidiabetic sulfonylureas and potassium channel openers.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Effects of tolbutamide on vascular ATP-sensitive potassium channels in humans. Comparison with literature data on glibenclamide and glimepiride

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Opening of potassium channels protects mitochondrial function from calcium overload

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Blockade of K(ATP) channels with glibenclamide does not abolish preconditioning during demand ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Does ischemic preconditioning occur in patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Influence of oral antidiabetic treatment on electrocardiac alterations induced by myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

Effects of glyburide on ischemia-induced changes in extracellular potassium and local myocardial activation: a potential new approach to the management of ischemia-induced malignant ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900916-1

7 January 2021

10.1016/S0735-1097(03)00916-1

Identifiers

DOI

1 reference

release_wdzjoywhtjb7hakeddro3qu7za

4 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wdzjoywhtjb7hakeddro3qu7za

24 November 2022

mapped directly with Wikidata item

1 reference